Delivery Order SPE2DB22D1017-SPE2DB24FF2UB
Award Date 2/12/24
Potential Completion Date 2/13/24
Potential Value $6.6K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Defense Logistics Agency (DLA) awarded a $3,239.99 firm fixed price delivery order contract to Amerisourcebergen Drug Corp, Corporate Office Division, to provide 4566054689 DROXIDOPA 200 MG CAPSULE 90S. This contract has an ultimate completion date of October 9, 2024 and is not set aside for a specific socioeconomic program. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies,...
- This $7,675.57 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) to provide DROXIDOPA 200 MG CAPSULE 90S. The contract has an ultimate completion date of October 10, 2024. Amerisourcebergen is a major pharmaceutical distributor that holds several Indefinite Delivery Contracts (IDCs) with federal agencies, including a $999,999,999 IDC with DLA Troop Support Medical for delivering a wide range of medical commodities to military...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an award value of $15,230.71 and is a delivery order for the supply of 4566601202 - DROXIDOPA 100 MG CAPSULE 90S. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the provision of 4,564,528,640 units of the pharmaceutical product Droxidopa 100 mg Capsule. The contract, valued at $36,956.64, was awarded by the Medical Supply Chain division of the Defense Logistics Agency (DLA) and has a completion date of May 8, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type. Amerisourcebergen, a major pharmaceutical distribution company, leverages its...
- This federal contract award is for the delivery of 4,564,359,527 units of the pharmaceutical product DROXIDOPA 100 MG CAPSULE 90S to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The contract, valued at $4,751.63, was awarded on April 22, 2024 to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The contract has a firm fixed price pricing type and an ultimate completion date of April 23, 2024. This award is associated with a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,467.79, is for the delivery of DROXIDOPA 100 MG CAPSULE 90S, a specialty medication. The contract is a Firm Fixed Price Delivery Order with a completion date of February 19, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award, valued at $2,793.64, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of 4567110760 - DROXIDOPA 200 MG CAPSULE 90S, with an ultimate completion date of January 27, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through...
- This federal contract award, valued at $16,195.07, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4566803424 DROXIDOPA 300 MG CAPSULE 90S, a specialty medication, with a completion date of December 30, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
- The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp's Corporate Office division to provide 90-count bottles of 300 mg Droxidopa capsules. The $17,658.57 contract has an ultimate completion date of August 19, 2024. AmerisourceBergen is a major pharmaceutical distributor that holds several Indefinite Delivery Contracts (IDCs) with federal agencies, including a $999,999,999 IDC with DLA Troop Support Medical for a wide range of...
- This federal contract award, with ID SPE2DB20D1100|SPE2DB25FA0F3, was issued by the Defense Logistics Agency (DLA) to the prime contractor AmerisourceBergen Drug Corp. The contract is for the delivery of 4566905952 DROXIDOPA 200 MG CAPSULE 90S, a pharmaceutical product, and has a ceiling value of $27,721.68. The contract type is Delivery Order with a Firm Fixed Price pricing structure, and the ultimate completion date is January 14, 2025. The place of performance is Conshohocken, PA 19428,...